Status:
RECRUITING
Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
Lead Sponsor:
Alexandria University
Conditions:
Scars
Insulin
Eligibility:
All Genders
12-60 years
Phase:
NA
Brief Summary
Recently, few studies have attempted to test the regenerative effects of human insulin application by microneedling on atrophic scars versus other topical preparations. However, the scars were limited...
Eligibility Criteria
Inclusion
- Patients aged 12 to 60 years
- Atrophic scars (traumatic or surgical)
- Completely healed scars
Exclusion
- Patients with a tendency or history of hypertrophic or keloidal scars
- Patients who received treatment for their scar in the past 3 months
- Diabetic patients or those with a history of Dysglycemia
- Pregnant, or lactating females
- Patients with active infection at the site of scar
- Patients currently receiving isotretinoin treatment or in the past month
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06021275
Start Date
October 1 2023
End Date
December 1 2024
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria University, Faculty of Medicine
Alexandria, Egypt